» Articles » PMID: 33246556

Short- and Long-Term Outcomes in Patients With New-Onset Persistent Left Bundle Branch Block After Transcatheter Aortic Valve Replacement

Abstract

Background: The impact of new-onset persistent left bundle branch block (LBBB) after transcatheter aortic valve replacement (TAVR) on all-cause mortality has been controversial.

Methods: We conducted a systematic review and meta-analysis of eleven studies (7398 patients) comparing the short- and long- outcomes in patients who had new-onset LBBB after TAVR vs. those who did not.

Results: During a mean follow-up of 20.5±14months, patients who had new-onset persistent LBBB after TAVR had a higher incidence of all-cause mortality (29.7% vs. 23.6%; OR 1.28 (1.04-1.58), p=0.02), rehospitalization for heart failure (HF) (19.5% vs. 17.3%; OR 1.4 (1.13-1.73), p=0.002), and permanent pacemaker implantation (PPMi) (19.7% vs. 7.1%; OR 2.4 (1.64-3.52), p<0.001) compared with those who did not. Five studies (4180 patients) reported adjusted hazard ratios (HR) for all-cause mortality; new LBBB remained associated with a higher risk of mortality (adjusted HR 1.43 (1.08-1.9), p<0.01, I=81%).

Conclusion: Post-TAVR persistent LBBB is associated with higher PPMi, HF hospitalizations, and all-cause mortality. While efforts to identify patients who need post-procedural PPMi are warranted, more studies are required to evaluate the best follow-up and treatment strategies, including the type of pacing device if required, to improve long-term outcomes in these patients.

Citing Articles

Transcatheter aortic valve implantation versus surgery: 4-year survival according to life expectancy.

Lodo V, Italiano E, Zingarelli E, Pietropaolo C, Pidello S, Buono G J Geriatr Cardiol. 2024; 21(9):846-854.

PMID: 39483264 PMC: 11522709. DOI: 10.26599/1671-5411.2024.09.005.


Conduction Abnormalities after Transcatheter Aortic Valve Implantation: Incidence, Impact and Management Using CT Data Interpretation.

Nuis R, van den Dorpel M, Adrichem R, Daemen J, van Mieghem N Interv Cardiol. 2024; 19:e12.

PMID: 39221063 PMC: 11363062. DOI: 10.15420/icr.2024.11.


2023 HRS/APHRS/LAHRS guideline on cardiac physiologic pacing for the avoidance and mitigation of heart failure.

Chung M, Patton K, Lau C, Dal Forno A, Al-Khatib S, Arora V J Arrhythm. 2023; 39(5):681-756.

PMID: 37799799 PMC: 10549836. DOI: 10.1002/joa3.12872.


Rationale and Design of the Randomized Bayesian Multicenter COME-TAVI Trial in Patients With a New Onset Left Bundle Branch Block.

Rivard L, Nault I, Krahn A, Daneault B, Roux J, Natarajan M CJC Open. 2023; 5(8):611-618.

PMID: 37720184 PMC: 10502429. DOI: 10.1016/j.cjco.2023.05.009.


2023 HRS/APHRS/LAHRS guideline on cardiac physiologic pacing for the avoidance and mitigation of heart failure.

Chung M, Patton K, Lau C, Dal Forno A, Al-Khatib S, Arora V Heart Rhythm. 2023; 20(9):e17-e91.

PMID: 37283271 PMC: 11062890. DOI: 10.1016/j.hrthm.2023.03.1538.